AAIM
MDGL icon

American Assets Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

American Assets Investment Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,000
Closed -$551K – 145
2025
Q2 		$551K Sell
2,000
-2,500
-56% -$745K 0.04% 141
2025
Q1 		$1.49M Buy
+4,500
New +$1.48M 0.13% 128

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

American Assets Investment Management's MDGL Position: Q3 2025 in Review

American Assets Investment Management sold out of Madrigal Pharmaceuticals (MDGL) in Q3 2025, closing a stake of 2,000 shares — an estimated $551K sold.

American Assets Investment Management first reported a position in MDGL in Q1 2025 and held it in 2 quarters. The position peaked at $1.49M in Q1 2025. 352 funds tracked by Wall St. Rank hold MDGL as of Q3 2025.

  • American Assets Investment Management reported no remaining Madrigal Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • American Assets Investment Management sold 2,000 Madrigal Pharmaceuticals shares in Q3 2025, an estimated $551K.
  • American Assets Investment Management first reported a position in Madrigal Pharmaceuticals in Q1 2025 and held it in 2 quarters.
  • American Assets Investment Management's Madrigal Pharmaceuticals position peaked at $1.49M in Q1 2025.
  • 352 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2025.

Based on American Assets Investment Management's 13F filing for Q3 2025, filed 5 Nov 2025.